Personal Information
Organization / Workplace
Dublin 4 Ireland
Website
www.ipha.ie
About
The IPHA represents the international research-based pharmaceutical industry in Ireland. Our members include both manufacturers of prescription medicines and non-prescription or consumer health care medicines.
Tags
healthcare
ireland
medicines
irish
pharma
drugs
ipha annual meeting 2009
pharmaceutical industry
ipha
value
contribution
patients
health service
hse
r&d
global health
demographics
research
development
challanges
demographic trends
chronic disease
exports
eli lilly
gsk
pfizer
novo nordisk
glaxosmithkline
novartis
wyeth
abbott
responsibility
cr
pharmaceutical
csr
astellas
lundbeck
sanofi
uhi
universal healthcare insurance
medicine
health insurance
healthcare funding
vhi
healthcare delivery
regulation
irish medicines board
economy
health technology assessment
hta
access
value for money
programme
health
care
health service executive
foreign direct investment
fdi
risk
self-care
arthritis
mens health
health service executice
prescribing
ageing population
department of health and children
self-medication
merck
See more
Presentations
(19)Likes
(1)Innovation Quotes -Motivational
guestfeb168
•
17 years ago
Personal Information
Organization / Workplace
Dublin 4 Ireland
Website
www.ipha.ie
About
The IPHA represents the international research-based pharmaceutical industry in Ireland. Our members include both manufacturers of prescription medicines and non-prescription or consumer health care medicines.
Tags
healthcare
ireland
medicines
irish
pharma
drugs
ipha annual meeting 2009
pharmaceutical industry
ipha
value
contribution
patients
health service
hse
r&d
global health
demographics
research
development
challanges
demographic trends
chronic disease
exports
eli lilly
gsk
pfizer
novo nordisk
glaxosmithkline
novartis
wyeth
abbott
responsibility
cr
pharmaceutical
csr
astellas
lundbeck
sanofi
uhi
universal healthcare insurance
medicine
health insurance
healthcare funding
vhi
healthcare delivery
regulation
irish medicines board
economy
health technology assessment
hta
access
value for money
programme
health
care
health service executive
foreign direct investment
fdi
risk
self-care
arthritis
mens health
health service executice
prescribing
ageing population
department of health and children
self-medication
merck
See more